DataAI National Summit’s Post

"With AI, the future of drug development is not just bright; it's illuminated with possibilities we once thought were unattainable." I’m thrilled to announce my latest article on how Artificial Intelligence (AI) is transforming the pharmaceutical industry, particularly in the realm of clinical trials. 🚀 In a recent panel discussion at CTIS2024, hosted by Genentech, I had the honor of sharing insights alongside esteemed leaders in the field, including Paquita Chang, Shun Zhang, Mukul Virmani, and Katherine Wang. Together, we delved into the promise and challenges of integrating AI into clinical trials, focusing on improving patient engagement and accelerating the development of life-saving treatments. In the article, I explore how AI is revolutionizing drug development—from target identification to optimizing clinical trial efficiency—leading to faster, cost-effective, and more patient-centric outcomes. #AI #ClinicalTrials #Innovation #Healthcare #PatientCentric #CTIS2024 #FutureOfMedicine #HealthcareInnovation Paquita Chang, Genentech, Roche Shun Zhang, AstraZeneca, Mukul Virmani, Gilead Sciences Katherine Wang, Palantir Technologies #PrecisionMedicine #Genentech #Roche #GileadSciences #Palentir #AstraZeneca Agility Pharmaceuticals American Association for Precision Medicine (AAPM) #AAPM_Health #AAPMHealth #News